Clinical Trial Update: Natesto Spermatogenesis Reboot [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update shows completion of a study evaluating Natesto (testosterone nasal gel) for restoring spermatogenesis in men with hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• NATESTO (testosterone)

Snippet

Sponsor: University of Florida | Conditions: Hypogonadism, Male | Phase 4 | Status: COMPLETED